What is the primary focus of ICH E6 (R3)?

What is the primary focus of ICH E6 (R3)?

• A. Enhancing trial marketing and publication speed.
• B. Quality by design, risk-based approach, subject protection.
• C. Standardizing global regulatory filings.
• D. Only focusing on data capture methods.

Answer: (B)

The main idea here is that ICH E6 (R3) centers on protecting trial participants and ensuring high-quality, reliable data by applying a risk-based, quality-by-design approach throughout the study. This revision emphasizes proactive quality management: identifying what could most impact safety and data integrity (critical to quality factors), planning controls up front, and tailoring monitoring and oversight to the specific risks of the trial. By doing so, trials are designed and conducted with built-in safeguards, robust documentation, proper vendor and training management, and a mindset of continuous improvement. The goal is to prevent problems before they occur and to align activities with patient safety and data integrity, rather than focusing on marketing speed, standardizing filings, or only the mechanics of data capture.

The main idea here is that ICH E6 (R3) centers on protecting trial participants and ensuring high-quality, reliable data by applying a risk-based, quality-by-design approach throughout the study. This revision emphasizes proactive quality management: identifying what could most impact safety and data integrity (critical to quality factors), planning controls up front, and tailoring monitoring and oversight to the specific risks of the trial. By doing so, trials are designed and conducted with built-in safeguards, robust documentation, proper vendor and training management, and a mindset of continuous improvement. The goal is to prevent problems before they occur and to align activities with patient safety and data integrity, rather than focusing on marketing speed, standardizing filings, or only the mechanics of data capture.